CN1181878C - Detumescence plaster - Google Patents

Detumescence plaster Download PDF

Info

Publication number
CN1181878C
CN1181878C CNB021589283A CN02158928A CN1181878C CN 1181878 C CN1181878 C CN 1181878C CN B021589283 A CNB021589283 A CN B021589283A CN 02158928 A CN02158928 A CN 02158928A CN 1181878 C CN1181878 C CN 1181878C
Authority
CN
China
Prior art keywords
treatment
fine powder
ointment
detumescence
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021589283A
Other languages
Chinese (zh)
Other versions
CN1424094A (en
Inventor
朱广义
欧阳波
程旦华
王诚宏
逢辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TANGGANGZI HOSPITAL ANSHAN CITY
Original Assignee
TANGGANGZI HOSPITAL ANSHAN CITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TANGGANGZI HOSPITAL ANSHAN CITY filed Critical TANGGANGZI HOSPITAL ANSHAN CITY
Priority to CNB021589283A priority Critical patent/CN1181878C/en
Publication of CN1424094A publication Critical patent/CN1424094A/en
Application granted granted Critical
Publication of CN1181878C publication Critical patent/CN1181878C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an externally-applied traditional Chinese medicinal preparation, namely a detumescence ointment, for treating joint swelling, which belongs to the technical field of medicines. The detumescence ointment is characterized in that one dosage of detumescence ointment comprises the medicinal ingredients according to weight ratio of 5000 to 8000g of bark of Chinese redbud, 2000 to 6000g of phellodendron bark, 1000 to 6000g of atractylodes rhizome, 5000 to 10000g of grassleaf sweetflag rhizome, 2000 to 6000g of red peony root and 3000 to 8000g of doubleteeth pubesscent angelica root. The medicinal ingredients taken by weight percentage are dried, sterilized and pulverized into fine powder of about 130 meshes, and the fine powder is separately packed by 200 g/bag. While in use, the fine powder is prepared into an ointment form by adding water. The present invention achieves the purposes of eliminating swelling, alleviating pain, improving functions and enhancing the quality of life by adopting various traditional Chinese medicines to optimize the prescription. The prepared externally-applied preparation has the advantages of convenient use, simple preparation process and low cost. The clinical tests of the detumescence ointment medicine of the present invention are finished. Through clinical application of 1020 patients with joint swelling by the treatment of the classification of diseases, the cure rate is 24.2%, and the total effective rate is 99.41%.

Description

A kind of external Chinese powder medicine for the treatment of arthroncus
Technical field
The present invention is a field of pharmaceutical technology, relates to a kind of external Chinese powder medicine for the treatment of arthroncus.
Background technology
Arthroncus is clinical common a kind of sign, seriously influences patient's orthobiosis and work.Many factors can cause arthroncus, as mechanical wear, the heavy burden of the non-line of force, crystallization deposition arthropathy or the like.The disease that causes arthroncus is a lot, and common have osteoarthritis, rheumatic arthropathy, crystal induced arthritis, bursitis or the like.Sickness rate for arthroncus does not now have unified report, and the pathogeny of arthroncus is due to illness because of different.At first tackling its primary disease and treat, secondly is symptomatic treatment.At present main Therapeutic Method has naturopathy and Drug therapy, and naturopathy required treatment time is longer, because treatment time is longer, the patient can not finish the required course of treatment sometimes.The side effect of oral drugs is bigger, and it is slow to take effect.Chinese medicine dialectical execute control, the difference of method such as prescription, dosage form, processing technique, curative effect is widely different.What Chinese patent 00123104.9 related to by retrieval is a kind of application compress, is a kind of ointment for treating traumatic injury, setting fracture and eliminating swelling.And Chinese patent 00114556.8 is a kind of repercussive Chinese medicine mastic that is used for more creating.The Chinese medicine for outer use that the treatment arthroncus is not also arranged at present.
Summary of the invention
The objective of the invention is provides a kind of external Chinese powder medicine for the treatment of arthroncus for overcoming above-mentioned treatment shortcoming.
A kind of external Chinese powder medicine content Description for the treatment of arthroncus of the present invention:
A kind of external Chinese powder medicine for the treatment of arthroncus of the present invention, it is characterized in that: it is made up of the component of following consumption, and ampoule is: Cortex cercis chinensis 5000~8000g, Cortex Phellodendri 2000~6000g, Rhizoma Atractylodis 1000~6000g, Rhizoma Acori Graminei 5000~10000g, Radix Paeoniae Rubra 2000~6000g and Radix Angelicae Pubescentis 3000~8000g.
It is made by following method: get it filled by consumption, dry sterilization, be crushed into 130 purpose fine powders, packing 200g/ bag tempers into paste during use.
The present invention is a kind of external Chinese powder medicine for the treatment of arthroncus, adopts plurality of Chinese to optimize prescription, the purpose that reaches reducing swelling and alleviating pain, improves function, improves the quality of living.Make external preparation, easy to use, preparation technology is simple, with low cost.Clinical trial of the present invention is finished, the patient of 1020 routine arthroncuss is carried out classification of diseases execute and control clinical practice, and wherein the course of disease is the longest 6 months, the shortest 7 days; Wherein: bursitis 284 examples, osteoarthritis 340 examples, rheumatoid arthritis 52 examples, wound 144 examples.
Criterion of therapeutical effect:
Cure: clinical symptoms and arthroncus complete obiteration, function are normally, daily life is not limited;
Significantly take a turn for the better: clinical symptoms and arthroncus disappear substantially, function of joint is roughly normal;
Take a turn for the better: clinical symptoms and arthroncus alleviate, and function of joint has improvement;
Invalid: clinical symptoms and arthroncus do not have obvious improvement.
Classification The example number Excellent Account for % Very Account for % Effectively Account for % Invalid Account for %
Bursitis osteoarthritis rheumatoid arthritis wound adds up to 284 340 252 144 1020 62 83 49 53 247 21.8 24.4 19.4 36.8 24.2 99 149 62 51 362 34.9 43.9 25 35.4 35.5 122 107 137 39 405 42.6 31.5 54.4 27.1 39.7 1 1 3 1 6 0.35 0.29 1.19 0.69 0.6
Cure 247 examples through clinical treatment, account for 24.2%, total effective 1014 examples, total effective rate is 99.41%.The shortest 10 days of treatment time, the longest 38 days, the efficacy consolidation relapse rate was lower, checked 879 examples with examining after 3 months to 2 years, and 31 example recurrences are arranged, and the state of an illness is preceding light than treatment, and relapse rate is to follow up a case by regular visits to 3.53% of check case.
The specific embodiment
Embodiment 1
Cause arthroncus patient 284 examples in March, 2000~November calendar year 2001 in Tanggangzi Hospital's prescription on individual diagnosis treatment bursitis, the prescription of seance amount medication is: Cortex cercis chinensis 5000g, Cortex Phellodendri 2000g, Rhizoma Atractylodis 2000g, Rhizoma Acori Graminei 6000g, Radix Paeoniae Rubra 3000g, Radix Angelicae Pubescentis 4000g.
The said medicine prescription got it filled after dry coarse powder, sterilize, be crushed into the fine powder about 130 orders, packing 200g/ bag, water reconciles into paste, and to spread on the affected part after the hot water bag heating, the lid layer soft plastic cloth covers two-layer towel again, increase temperature with hot water bag, applied 2~3 hours every day.Make medicine act on body by skin, get rid of evils and set upright by heating power, warming the meridian and promoting blood circulation, the circulation QI and blood reaches the purpose of curing the disease.Reach 99.4% through the treatment total effective rate.
Embodiment 2
Cause arthroncus patient 340 examples in March, 2000~November in Anshan soup mound hospital admission treatment rheumatoid arthritis, the prescription of seance amount medication is: Cortex cercis chinensis 8000g, Cortex Phellodendri 3000g, Rhizoma Atractylodis 4000, Rhizoma Acori Graminei 7000g, Radix Paeoniae Rubra 4000g, Radix Angelicae Pubescentis 6000g.
The said medicine prescription got it filled after dry coarse powder, sterilize, be crushed into the fine powder about 130 orders, packing 200g/ bag, water reconciles into paste, and to spread on the affected part after the hot water bag heating, the lid layer soft plastic cloth covers two-layer towel again, increase temperature with hot water bag, every order applied 2~3 hours.Make medicine act on body by skin, get rid of evils and set upright by heating power, warming the meridian and promoting blood circulation, the venting QI-blood that relaxes reaches the purpose of curing the disease.Reach 98.8% through the treatment total effective rate.
Embodiment 3
Cause arthroncus patient 144 examples in Anshan soup mound hospital admission treatment wound year November in April, 2000~2002, the prescription of seance amount medication is: Cortex cercis chinensis 6000g, Cortex Phellodendri 6000g, Rhizoma Atractylodis 3000, Rhizoma Acori Graminei 6000g, Radix Paeoniae Rubra 3000g, Radix Angelicae Pubescentis 3000g.
The said medicine prescription got it filled after dry coarse powder, sterilize, be crushed into the fine powder about 130 orders, packing 200g/ bag, water reconciles into paste, and to spread on the affected part after the hot water bag heating, the lid layer soft plastic cloth covers two-layer towel again, increase temperature with hot water bag, applied 2~3 hours every day.Make medicine act on body by skin, get rid of evils and set upright by heating power, warming the meridian and promoting blood circulation, the venting QI-blood that relaxes reaches the purpose of curing the disease.Reach 99.3% through the treatment total effective rate.
Have promoting blood circulation to restore menstrual flow, subduing swelling and detoxicating according to pharmacological research proof Cortex cercis chinensis; Radix Paeoniae Rubra, Rhizoma Atractylodis, Radix Angelicae Pubescentis have the effect of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, expelling wind and removing dampness; The hot temperature of loosing of Rhizoma Acori Graminei is logical.The present invention serves as the comprehensive prescription of treatment with blood circulation promoting and blood stasis dispelling, dredging the meridian.By eliminating swelling, ease the pain, improve function.

Claims (2)

1, a kind of external Chinese powder medicine for the treatment of arthroncus, it is characterized in that: it is made up of the component of following consumption: Cortex cercis chinensis 5000~8000g, Cortex Phellodendri 2000~6000g, Rhizoma Atractylodis 1000~6000g, Rhizoma Acori Graminei 5000~10000g, Radix Paeoniae Rubra 2000~6000g and Radix Angelicae Pubescentis 3000~8000g.
2, a kind of external Chinese powder medicine as claimed in claim 1, it is characterized in that: it is made by following method: get it filled by consumption, dry sterilization, be crushed into 130 purpose fine powders.
CNB021589283A 2002-12-27 2002-12-27 Detumescence plaster Expired - Fee Related CN1181878C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021589283A CN1181878C (en) 2002-12-27 2002-12-27 Detumescence plaster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021589283A CN1181878C (en) 2002-12-27 2002-12-27 Detumescence plaster

Publications (2)

Publication Number Publication Date
CN1424094A CN1424094A (en) 2003-06-18
CN1181878C true CN1181878C (en) 2004-12-29

Family

ID=4753212

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021589283A Expired - Fee Related CN1181878C (en) 2002-12-27 2002-12-27 Detumescence plaster

Country Status (1)

Country Link
CN (1) CN1181878C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526387B (en) * 2012-02-27 2014-01-15 天津中医药大学 Medicinal composition for treating early-stage diabetic foot and preparation method thereof
CN104138480A (en) * 2013-05-08 2014-11-12 百家康健(天津)生物科技有限公司 Redness swelling eliminating ointment
CN104116871A (en) * 2014-08-11 2014-10-29 周盈裕 Traditional Chinese medicine paste for treating ulcers
CN104887869A (en) * 2015-05-24 2015-09-09 太仓思瑞生物科技有限公司 Plaster for treating osteoarthritis
CN104887868A (en) * 2015-05-24 2015-09-09 太仓思瑞生物科技有限公司 Plaster for treating arthritis
CN105582474A (en) * 2016-02-02 2016-05-18 赵佳睿 Paste capable of stopping pain and relieving swelling

Also Published As

Publication number Publication date
CN1424094A (en) 2003-06-18

Similar Documents

Publication Publication Date Title
CN1091609C (en) Tincture for treating rheumatoid arthritis and its preparing process
CN1181878C (en) Detumescence plaster
CN1124156C (en) Chinese-medicinal pills for treating rheumatism and preparing process thereof
CN1302800C (en) Chinese traditional medicine preparation for curing gastric ulcer
CN1814245A (en) Chinese medicine remedy for treating cervical vertebra disease
CN1698735A (en) Medicine for treating psoriasis
CN1418696A (en) Traditional Chinese medicine prepn. for treating cervical vertebra disease
CN1135909A (en) Medicine for hyperosteogeny and wind-cold syndrome
CN1478525A (en) Medicated wine for treating traumatic injury
CN1134837A (en) Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin"
CN1148214C (en) Medicine for curing bronchial asthma disease and its preparing method
CN1181879C (en) Analgestic plaster
CN1074670C (en) Medicine for the treatment of rheumatism and arthritis
CN1052908C (en) "Chanhouning" and its preparation method
CN1294984C (en) Combination of Chinese traditional medicine for treating rheumatoid arthritis and artjritis pauperum
CN1236809C (en) Trauma treating medicament and method for making same
CN1381250A (en) Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis
CN1404850A (en) Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine
CN1615929A (en) Medicine for treating wind-dampness syndrome
CN1814083A (en) Collateral-flow-activating pain-relieving ointment of Radix Torricelliae Angucatae for treating affection by dampness
CN1899564A (en) External use medicine for treating hyperosteogeny and protrusion of intervertebral disc
CN1911357A (en) Medicinal composition for treating hyperosteogency
CN1422639A (en) Dral medicine for treating rheumatism and atrophic diseases
CN1076201C (en) Chinese medicine for treating rheumatoid disease
CN1181864C (en) Pain eliminating liquor No.1

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee